Clinical Trial Site

Prague 140 59

4 studies enrolling now · 9 studies all time

What they study most

ANCA-Associated Vasculitis, Acute Hepatic Porphyria, Advanced Breast Cancer, Breast Cancer, Dermatomyositis, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, Metastatic Breast Cancer, Transthyretin Amyloidosis (ATTR) With Cardiomyopathy

Studies at this site

• TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Recruiting now
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis — Running, not enrolling
• APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy) — Completed
• A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Enrolling by invitation
• A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis — Running, not enrolling
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed
• EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP) — Completed